Intercept Pharmaceuticals, Inc. ICPT was a big mover last session, as the company saw its shares rise more than 8% on the day. The move came on solid volume too with far more shares changing hands than in a normal session. This breaks the recent trend of the company, as the stock is now trading above the volatile price range of $43.13 to $48.82 in the past one-month time frame.
The company’s Zacks Consensus Estimate for the current quarter has moved higher over the past few weeks, suggesting that more solid trading could be ahead for Intercept. So make sure to keep an eye on this stock going forward to see if this recent jump can turn into more strength down the road.
Intercept currently has a Zacks Rank #3 (Hold) while its Earnings ESP is positive.
Intercept Pharmaceuticals, Inc. Price
Intercept Pharmaceuticals, Inc. price | Intercept Pharmaceuticals, Inc. Quote
Investors interested in the Medical – Biomedical and Genetics industry may consider Bio-Techne Corporation TECH, which has a Zacks Rank #1 (Strong Buy). You can see the complete list of today’s Zacks #1 Rank stocks here.
Zacks’ Single Best Pick to Double
From thousands of stocks, 5 Zacks experts each picked their favorite to gain +100% or more in months to come. From those 5, Zacks Director of Research, Sheraz Mian hand-picks one to have the most explosive upside of all.
With users in 180 countries and soaring revenues, it’s set to thrive on remote working long after the pandemic ends. No wonder it recently offered a stunning $600 million stock buy-back plan.
The sky’s the limit for this emerging tech giant. And the earlier you get in, the greater your potential gain.
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
To read this article on Zacks.com click here.
Zacks Investment Research
